Recent Posts
- Baudax Bio Acquires TeraImmune, Inc.
- Sable Therapeutics Announces Licensing Agreement with Shanghai Liuqiang Medical Technology Co.
- Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
- Egret Therapeutics Announces the Addition of Three New Members to its Scientific Advisory Board
- Egret Therapeutics completes oversubscribed pre-A financing round
Recent Comments